| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |